Jim Cramer’s Mad Dash: Janet Yellen Was Wrong about Biotechs

– On CNBC’s Mad Dash, Cramer discussed the powerful performance of biotech stock Intercept (ICPT) which saw a 16.59% increase on Tuesday after strong data for its liver disease treatment. Cramer More...